Skip to content
Tuesday 8 September 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,822.13
-0.08%
DAX
26,006.53
0.00%
CAC 40
8,306.15
0.00%
STOXX 50
6,403.99
0.00%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Sponsored Ad Feature is produced by an advertiser with the specific intent to promote a product and is not produced by the Morning Wire team.
Wednesday 29 December 2021 9:00 am  |  Updated:  Friday 24 December 2021 9:48 am

Try a new drug-free treatment for Alzheimer’s

By:

Add as a preferred source on Google

NeuroPulse Transcranial Pulse Stimulation is a new treatment for Alzheimer’s disease and mild to moderate dementia.

It’s currently the only drug-free treatment clinically proven to enhance and maintain cognitive ability in Alzheimer’s patients. The treatment is comfortable and non-invasive, with just six 30-minute treatments over two weeks, which can improve mild to moderate Alzheimer’s by 10 points on the CERAD scale.

It works through the TPS passing high-frequency acoustic pulses through the patient’s head to stimulate deep cerebral regions of the brain, which stimulates neural growth factors. To perform the procedure, a machine called a Neurolith is used; it was created by Storz Medical, one of Europe’s leading medical machine manufacturers since 1987, and is sold in the UK by Venn Healthcare.

For more information on the treatment and eligibility, visit alzheimersclinics.co.uk

Read more

Prothena Reports Second Quarter 2026 Financial Results and Business Highlights

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Life&Style

Categories

  • Morning Wire Content
  • Life&Style

Trending Articles

  • Iceland boss Richard Walker vows to set up shop on Falkland Islands

  • Hedge fund billionaire Chris Rokos joins UK wealth exodus 

  • Britain ‘taxing itself to death,’ Burnham warned

  • £74m for branded condoms? UK must stop spaffing cash on foreign aid

  • As it happened: FTSE 100 inche up as oil holds gains; Healey says UK paying ‘Truss penalty’

More from Morning Wire

  • Prothena Reports Second Quarter 2026 Financial Results and Business Highlights

    Business Wire
  • Nanochon Receives Regulatory Approval from Panamá’s Ministry of Health to Initiate First-in-Human Clinical Study of Chondrograft™

    Business Wire
  • U.S. FDA approves ViiV Healthcare’s Tivicay PD, helping close a critical HIV treatment gap for young children

    Business Wire
  • Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award

    Business Wire
  • Compass Pathways Announces Second Quarter and First Half 2026 Financial Results and Business Highlights

    Business Wire
  • Cycle Pharmaceuticals Selects Forma Life Sciences to Establish U.S. Commercial Supply for FDA-Approved CAVHANZA™ (nilotinib) Orally Disintegrating Tablets

    Business Wire
  • Limbic Becomes First AI-Led Mental Healthcare Company Selected for FDA TEMPO

    Business Wire
  • Align Technology Prevails in China Patent Infringement Action Against Angelalign

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook